IOL for reducing secondary opacification
    3.
    发明授权
    IOL for reducing secondary opacification 失效
    减少二次不透明度的IOL

    公开(公告)号:US5549670A

    公开(公告)日:1996-08-27

    申请号:US437656

    申请日:1995-05-09

    IPC分类号: A61F2/00 A61F2/16 H04L9/18

    摘要: An IOL implantable in an eye including an optic having an optical portion for directing light toward the retina of the eye and a cell barrier portion for inhibiting cell growth from the eye in front of or in back of the optical portion. The cell barrier portion circumscribes the optical portion, is incapable of focusing light on the retina and includes an irregularly configured structure, for example, irregular grooves. At least one elongated fixation member is coupled to the optic for use in fixing the optic in the eye.

    摘要翻译: 可植入眼睛中的IOL,包括具有用于将光引导到眼睛的视网膜的光学部分的光学元件,以及用于在光学部分的前方或后面抑制细胞从眼睛生长的细胞屏障部分。 细胞屏障部分围绕光学部分,不能将光聚焦在视网膜上并且包括不规则构造的结构,例如不规则凹槽。 至少一个细长的固定构件联接到光学元件以用于将光学元件固定在眼睛中。

    IOL for reducing secondary opacification
    4.
    发明授权
    IOL for reducing secondary opacification 失效
    减少二次不透明度的IOL

    公开(公告)号:US5693094A

    公开(公告)日:1997-12-02

    申请号:US627723

    申请日:1996-04-02

    IPC分类号: A61F2/00 A61F2/16

    摘要: An IOL implantable in an eye including an optic having an optical portion for directing light toward the retina of the eye and a cell barrier portion for inhibiting cell growth from the eye in front of or in back of the optical portion. The cell barrier portion circumscribes the optical portion, is incapable of focusing light on the retina and includes an irregularly configured structure, for example, irregular grooves. At least one elongated fixation member is coupled to the optic for use in fixing the optic in the eye.

    摘要翻译: 可植入眼睛中的IOL,包括具有用于将光引导到眼睛的视网膜的光学部分的光学元件,以及用于在光学部分的前方或后面抑制细胞从眼睛生长的细胞屏障部分。 细胞屏障部分围绕光学部分,不能将光聚焦在视网膜上并且包括不规则构造的结构,例如不规则凹槽。 至少一个细长的固定构件联接到光学元件以用于将光学元件固定在眼睛中。

    Biostable corneal implants
    7.
    发明授权
    Biostable corneal implants 失效
    生物稳定性角膜植入物

    公开(公告)号:US5632773A

    公开(公告)日:1997-05-27

    申请号:US616786

    申请日:1996-03-15

    IPC分类号: A61F2/00 A61F2/14 A61L27/24

    摘要: Corneal implants and methods for producing such implants are disclosed. The present corneal implants comprise a lens body which is optically clear and is structured to be surgically attached in or on the cornea of a mammalian eye, the lens body including a hydrogel composition containing water, a collagen component and a polymeric material covalently bonded to the collagen component. The hydrogel composition has enhanced biostability relative to an identical hydrogel composition without the polymeric material.

    摘要翻译: 公开了角膜植入物和用于生产这种植入物的方法。 本发明的角膜植入物包括光学透明的透镜体,其被构造成手术附着在哺乳动物眼睛的角膜中或上面,所述透镜体包括水凝胶组合物,所述水凝胶组合物含有水,胶原组分和共价键合到 胶原成分。 相对于没有聚合物材料的相同的水凝胶组合物,水凝胶组合物具有增强的生物稳定性。

    Corneal implants and methods for producing same
    8.
    发明授权
    Corneal implants and methods for producing same 失效
    角膜植入物及其生产方法

    公开(公告)号:US5433745A

    公开(公告)日:1995-07-18

    申请号:US135875

    申请日:1993-10-13

    IPC分类号: A61F2/14 A61F2/16

    CPC分类号: A61F2/142 A61F2/14

    摘要: New corneal implants and methods for producing such implants are disclosed. The present corneal implants comprise a lens body which is optically clear and is structured to be surgically attached in or on the cornea of a mammalian eye, the lens body including a core having an outer surface and made of a hydrogel composition containing water and a hydrophilic polymeric material, and a coating comprising a synthetic polymeric component located on the outer surface, covalently bonded to the hydrogel composition and having enhanced ability to support epithelial cell growth and/or adhesion relative to the hydrogel composition.

    摘要翻译: 公开了新的角膜植入物和用于生产这种植入物的方法。 本发明的角膜植入物包括光学透明的透镜体,其被构造成手术附着在哺乳动物眼睛的角膜中或上面,所述透镜体包括具有外表面并且由含有水和亲水性的水凝胶组合物制成的芯 聚合物材料和包含位于外表面上的合成聚合物组分的涂层,共价键合到水凝胶组合物上,并具有增强的相对于水凝胶组合物支持上皮细胞生长和/或粘附的能力。

    Solution for storing bioprosthetic tissue used in a biological prosthesis
    9.
    发明授权
    Solution for storing bioprosthetic tissue used in a biological prosthesis 有权
    用于存储生物假体中使用的生物假体组织的溶液

    公开(公告)号:US07989157B2

    公开(公告)日:2011-08-02

    申请号:US11032923

    申请日:2005-01-11

    IPC分类号: A01N1/00 A01N1/02

    CPC分类号: A01N1/02 A01N1/0226

    摘要: A method for processing biological tissue used in biological prostheses includes providing a tissue procurement solution formed from a phosphate buffered saline (PBS) solution and a chelating agent. The tissue is transferred from the tissue procurement solution and undergoes chemical fixation. The fixed tissue is then immersed in a series of fresh bioburden reduction process (BRP) solutions to extract phospholipids. The tissue procurement solution reduces the bioburden on the stored tissue and preserves tissue architecture by minimizing tissue swelling. The tissue procurement solution further reduces calcium from the incoming water and/or tissue, and inhibits enzymes that digest the collagen matrix. The serial immersion of the tissue in the fresh bioburden solutions ensures optimal extraction of phospholipids thereby mitigating subsequent calcification of the tissue.

    摘要翻译: 用于处理生物假体中使用的生物组织的方法包括提供由磷酸盐缓冲盐水(PBS)溶液和螯合剂形成的组织采购溶液。 组织从组织采购溶液转移并进行化学固定。 然后将固定的组织浸入一系列新鲜的生物负载降低过程(BRP)溶液中以提取磷脂。 组织采购解决方案减少存储组织的生物负载,并通过最小化组织肿胀来保持组织结构。 组织采购解决方案进一步减少来自进入的水和/或组织的钙,并且抑制消化胶原蛋白基质的酶。 将组织连续浸入新鲜的生物负载溶液中确保磷脂的最佳提取,从而减轻随后的组织钙化。